Find Grants for Advance Search

Find out if you qualify for verified grants for Higher Education. Discover your eligibility and key funding details for Higher Education from major foundations and government agencies.

Total Dollars Available
$ 100 Trillion

Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-299

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.273, 93.307, 93.399

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

Deadline: January 7, 2027


Opportunity Number: PAR-25-025

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.838, 93.839, 93.233, 93.837

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

Deadline: January 7, 2027


Opportunity Number: PAR-25-026

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.840, 93.233, 93.839, 93.837, 93.838

NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)

Deadline: May 7, 2026


Opportunity Number: PAR-25-239

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.121

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Deadline: November 5, 2027


Opportunity Number: PAR-25-297

Agency: National Institutes of Health

Open Date: December 4, 2024

Close Date: November 5, 2027

Status: Posted

CFDA Numbers: 93.866

Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)

Deadline: January 7, 2027


Opportunity Number: PAR-25-310

Agency: National Institutes of Health

Open Date: December 3, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.242

NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-251

Agency: National Institutes of Health

Open Date: December 3, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.855

NSF Scholarships in Science, Technology, Engineering, and Mathematics Program

Deadline: March 2, 2027


Opportunity Number: 25-514

Agency: U.S. National Science Foundation

Open Date: December 3, 2024

Close Date: March 2, 2027

Status: Posted

CFDA Numbers: 47.076

Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-134

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.855, 93.233, 93.213, 93.121, 93.399, 93.853, 93.396, 93.395, 93.273, 93.879, 93.846, 93.847, 93.242, 93.286, 93.113, 93.361, 93.279, 93.394, 93.839, 93.837, 93.838, 93.173, 93.393, 93.859, 93.172, 93.840, 93.310, 93.866, 93.867, 93.865

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)

Deadline: November 12, 2027


Opportunity Number: PAR-25-215

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 12, 2027

Status: Posted

CFDA Numbers: 93.853

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)

Deadline: November 12, 2027


Opportunity Number: PAR-25-216

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 12, 2027

Status: Posted

CFDA Numbers: 93.853

FOUNDATIONS OF TRUSTED SYSTEMS

Deadline: December 5, 2028


Opportunity Number: FA875025S7001

Agency: Air Force -- Research Lab

Open Date: December 2, 2024

Close Date: December 5, 2028

Status: Posted

CFDA Numbers: 12.800

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

Deadline: November 16, 2027


Opportunity Number: PAR-25-265

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 16, 2027

Status: Posted

CFDA Numbers: 93.865

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

Deadline: November 16, 2027


Opportunity Number: PAR-25-266

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 16, 2027

Status: Posted

CFDA Numbers: 93.865

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

Deadline: November 13, 2026


Opportunity Number: PAR-25-270

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 13, 2026

Status: Posted

CFDA Numbers: 93.213

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

Deadline: November 13, 2026


Opportunity Number: PAR-25-269

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 13, 2026

Status: Posted

CFDA Numbers: 93.213

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

Deadline: November 13, 2026


Opportunity Number: PAR-25-271

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 13, 2026

Status: Posted

CFDA Numbers: 93.213

NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Deadline: January 6, 2028


Opportunity Number: PAR-25-188

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: January 6, 2028

Status: Posted

CFDA Numbers: 93.121

Alcohol Health Services Research (R01 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PA-25-245

Agency: National Institutes of Health

Open Date: November 27, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.273

Alcohol Health Services Research (R34 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-192

Agency: National Institutes of Health

Open Date: November 27, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.273

Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)

Deadline: September 7, 2026


Opportunity Number: PA-25-163

Agency: National Institutes of Health

Open Date: November 27, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.273

Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)

Deadline: September 7, 2026


Opportunity Number: PAR-25-193

Agency: National Institutes of Health

Open Date: November 27, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.273

Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)

Deadline: October 15, 2027


Opportunity Number: PAR-25-179

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)

Deadline: October 15, 2027


Opportunity Number: PAR-25-181

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)

Deadline: October 15, 2027


Opportunity Number: PAR-25-182

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

×

Request Grant Support from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.